Targeting oxidant-dependent pathways to improve stroke outcomes in COPD

Vlahos, Ross (Primary Chief Investigator (PCI))
Bozinovski, Steven (Chief Investigator (CI))
Crack, Peter John (Chief Investigator (CI))
Miller, Alyson (Chief Investigator (CI))
Hamilton, Justin (Chief Investigator (CI))
Irving, Louis B, (Chief Investigator (CI))
Steinfort, Daniel P. (Chief Investigator (CI))

Australian Centre for Blood Diseases

Project: Research

2 Article

2 results

2020

Disrupting the platelet internal membrane via PI3KC2α inhibition impairs thrombosis independently of canonical platelet activation
Selvadurai, M. V., Moon, M. J., Mountford, S. J., Ma, X., Zheng, Z., Jennings, I. G., Setiabakti, N. M., Iman, R. P., Brazilek, R. J., Z Abidin, N. A., Chicanne, G., Severin, S., Nicholls, A. J., Wong, C. H. Y., Rinckel, J-Y., Eckly, A., Gachet, C., Nesbitt, W. S., Thompson, P. E. & Hamilton, J. R., 22 Jul 2020, In: Science Translational Medicine. 12, 553, 15 p., eaar8430.
Research output: Contribution to journal › Article › Research › peer-review

22 Citations (Scopus)
2019

The PI 3-kinase PI3KC2α regulates mouse platelet membrane structure and function independently of membrane lipid composition
Selvadurai, M. V., Brazilek, R. J., Moon, M. J., Rinckel, J. Y., Eckly, A., Gachet, C., Meikle, P. J., Nandurkar, H. H., Nesbitt, W. S. & Hamilton, J. R., 1 Jan 2019, In: FEBS Letters. 593, 1, p. 88-96 9 p.
Research output: Contribution to journal › Article › Research › peer-review

11 Citations (Scopus)